Date: 2025/02/19 - 17:31
An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help lower their stroke and heart attack risk, a new study has found.
Date: 2025/02/19 - 01:00
A new study confirms previous findings that hormonal birth control is associated with an increased risk of heart attack and stroke. While the vaginal ring and the patch had the highest cardiovascular risk, the overall risk remains low.
Date: 2025/02/10 - 21:00
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.